Skip to content

Screener

Eligibility screening

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With…

Sponsored by Regeneron PharmaceuticalsStudy detailsClinicalTrials.gov

152 US sites in AR, AZ, CA, CO +29

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.